Results 251 to 260 of about 1,602,505 (289)
Some of the next articles are maybe not open access.

Live-attenuated chikungunya virus vaccine

Cell
Although Chikungunya fever does not a have a high fatality rate (
Lisa F P, Ng, Laurent, Rénia
openaire   +2 more sources

Live Attenuated Vaccines for Pandemic Influenza

2009
In this chapter, we will review the development of and clinical experience with the currently licensed seasonal live attenuated influenza vaccines (LAIV) and preclinical studies of H5, H7, and H9 live attenuated pandemic influenza vaccine candidates. Vectored vaccine approaches will not be reviewed in this chapter.
Grace L, Chen, Kanta, Subbarao
openaire   +2 more sources

Live attenuated vaccines for human use

Current Opinion in Biotechnology, 1992
Live attenuated vaccines have been successfully used for the prevention of a number of viral and bacterial diseases. Several vaccine strains have been utilized recently as expression vectors for cloned heterologous antigens. Through the use of recombinant DNA technology, candidate vaccine strains and vector systems have been developed and are ...
openaire   +2 more sources

Live attenuated influenza vaccine for children

Drug and Therapeutics Bulletin, 2017
For many years, the UK seasonal influenza vaccination programme has been offered to people at higher risk from the complications of influenza infection, including those aged over 65 years and anyone aged over 6 months who is in a clinical risk group.1 In 2012, the Joint Committee on Vaccination and Immunisation (JCVI) recommended extending seasonal ...
openaire   +2 more sources

Generation of a Live Attenuated Influenza A Vaccine by Proteolysis Targeting

Nature Biotechnology, 2022
Chengxin Zhang, Longlong Si, Haiqing Bai
exaly  

A Single-Dose Live-Attenuated YF17D-Vectored SARS-CoV-2 Vaccine Candidate

Nature, 2021
Koen Van Laere   +2 more
exaly  

Studies with Live Attenuated Influenza Vaccines

American Journal of Clinical Pathology, 1979
G, Florent, F, André
openaire   +2 more sources

Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence

Cell Host and Microbe, 2020
Raul Andino   +2 more
exaly  

A Live-Attenuated SARS-CoV-2 Vaccine Candidate With Accessory Protein Deletions

Nature Communications, 2022
Pei-Yong Shi   +2 more
exaly  

Home - About - Disclaimer - Privacy